Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001397-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X71_splice	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	NA	MSKCC	9	37015192	37015192	C	A	9:g.37015192C>A	ENST00000358127.4:c.213-1G>T							17							73				0.3492						LUAD				1	Female	Former light		Matched	18.8556401102			NO	FGFR1	IMPACT341	NO	MSKCC	0	Brain	Adenocarcinoma	Lung	YES	Tumor	482	YES	Metastasis		IV	NO	YES		AWD																													
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0004890-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R243M	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.02;Polyphen-2: impact: probably_damaging, score: 0.962	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	36966598	36966598	C	A	9:g.36966598C>A	ENST00000358127.4:c.728G>T	0.54		245	205		423	12	6/10						69		NO		0.5565						LUAD		1.83		1	Female			Matched	10.7659166738					IMPACT410																							1:Progressed																	0.56	Commercial	2	11.32075472		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0006071-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	N148K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.6;Polyphen-2: impact: benign, score: 0.034	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	37006501	37006501	G	T	9:g.37006501G>T	ENST00000358127.4:c.444C>A	0.84		660	124		562	18	4/10						53		NO		0.4911						LUAD		4.73		1	Female			Matched	17.6169545571					IMPACT410																							1:Progressed																	0.49	Commercial	2	18.86792453	0	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0002637-T01-IM3	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	T386N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious_low_confidence, score: 0.01;Polyphen-2: impact: benign, score: 0.185	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	36840576	36840576	G	T	9:g.36840576G>T	ENST00000358127.4:c.1157C>A	0.79		479	128		320	17	10/10						53		YES		0.6353						LUNE		27.6		1	Male			Matched	18.8556401102					IMPACT341																							0:Not Progressed																	0.64	Clinical trial	1	17.34693878	0	Ever	Combination
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0012817-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A379D	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious_low_confidence, score: 0.01;Polyphen-2: impact: benign, score: 0.319	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	36840597	36840597	G	T	9:g.36840597G>T	ENST00000358127.4:c.1136C>A	0.10		81	751		606	34	10/10						54		YES		0.0410						LUAD		7.2		1	Male			Matched	32.2977500213					IMPACT410																							0:Not Progressed																	0.04	Commercial	2	32.0754717		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s41	Lung cancer	Lung Adenocarcinoma	T386N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious_low_confidence, score: 0.01;Polyphen-2: impact: benign, score: 0.185	Missense_Mutation	SNP			NA	NA	MSKCC	9	36840576	36840576	G	T	9:g.36840576G>T	ENST00000358127.4:c.1157C>A	0.78		43	12			901	10/10								Durable Clinical Benefit			Non-Squamous			840		LUAD		13.5359		1	Male			Matched	30.0333333333																												0:Censor					53	CR	0	A*02:01	A*03:01	B*18:01	B*55:01	C*03:03	C*07:01	0.0	2852	Former							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000671-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A279S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 1;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	36923427	36923427	C	A	9:g.36923427C>A	ENST00000358127.4:c.835G>T							38	7/10						63				0.2308						LUAD				1	Female	Former heavy		Matched	42.1479014227			NO	PIK3CA	IMPACT341	NO	MSKCC	1	Brain	Adenocarcinoma	Lung	YES	Tumor	729	NO	Metastasis		IB	NO	NO	65	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004729-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	P258T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.39;Polyphen-2: impact: probably_damaging, score: 0.981	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	36966554	36966554	G	T	9:g.36966554G>T	ENST00000358127.4:c.772C>A							11	6/10			rs1288922202			78		YES		0.1551						LUAD				1	Female	Former heavy		Matched	10.7659166738			YES	EGFR	IMPACT410	NO	MSKCC	0	Epidural	Adenocarcinoma	Lung	YES	Tumor	632	YES	Metastasis	Note: The MLL, CBL, KDM5A, RAD52 and ETV6 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	IV	YES	NO		AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000491-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	H318L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: probably_damaging, score: 0.954	Missense_Mutation	SNP	Diploid	1	SOMATIC	NA	MSKCC	9	36882060	36882060	T	A	9:g.36882060T>A	ENST00000358127.4:c.953A>T							26	8/10						59		NO		0.1482						LUAD				1	Male	Former heavy		Matched	28.8380378155			YES	NF1_truncating	IMPACT341	NO	MSKCC	0	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	491	YES	Metastasis		IV	YES	YES	40	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004890-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R243M	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.02;Polyphen-2: impact: probably_damaging, score: 0.962	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	36966598	36966598	C	A	9:g.36966598C>A	ENST00000358127.4:c.728G>T							12	6/10						68				0.5565						LUAD				1	Female	Former heavy		Matched	10.7659166738			NO	KRAS	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	515	YES	Primary		IV	NO	YES	50	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000671-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E121D	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.17;Polyphen-2: impact: benign, score: 0.023	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	37015041	37015041	C	G	9:g.37015041C>G	ENST00000358127.4:c.363G>C							38	3/10						63				0.2308						LUAD				1	Female	Former heavy		Matched	42.1479014227			NO	PIK3CA	IMPACT341	NO	MSKCC	1	Brain	Adenocarcinoma	Lung	YES	Tumor	729	NO	Metastasis		IB	NO	NO	65	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0006071-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	N148K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.6;Polyphen-2: impact: benign, score: 0.034	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	37006501	37006501	G	T	9:g.37006501G>T	ENST00000358127.4:c.444C>A							18	4/10						52				0.4911						LUAD				1	Female	Former heavy		Matched	17.6169545571			NO	KIT	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	752	YES	Primary	Note: The SMAD4 exon9 mutations all occur in cis (same allele).      Note: Copy number profile is suggestive of an intrangenic gain of NCOA3 exons 2-17.	IV	NO	YES	70	AWD																													
